A Justified Limit for the Identification Threshold of Organic Impurities in Drug-Linker Intermediates Used to Produce Antibody-Drug Conjugates

1:45 pm - Tuesday 9th March 2027

  • Showcasing a science-based justification for D-L related impurities identification threshold
  • Analysing a 47-ADC data set to justify the proposal of related impurities identification threshold
  • Applying four independent quantitative criteria to address what impurity levels are all four criteria satisfied for all 47 clinical-stage ADCs in our dataset

Speakers:

Principal Scientist - New Modalities
AstraZeneca